Circulating plasma exosomal miR-146b-5p regulates microglial-mediated neuroinflammation through the TRAF6/NF-κB

Fuan Zhang1, Chong Han1, Jiao Chen2

  • 1Department of Neurosurgery, Affiliated Hospital of Zunyi Medical University, No. 149, Dalian Road, Zunyi, Guizhou, 563000, China.

Life Sciences
|October 16, 2025
PubMed
Abstract

Insights

Reduced miR-146b-5p in plasma exosomes after intracerebral hemorrhage (ICH) impairs microglial polarization. Restoring miR-146b-5p offers neuroprotection by targeting the TRAF6/NF-κB pathway, suggesting new ICH therapies.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Intracerebral hemorrhage (ICH) triggers neuroinflammation involving microglial polarization.
  • The role of microRNA-146b-5p (miR-146b-5p) in ICH-induced microglial changes is not fully understood.

Purpose of the Study:

  • To investigate the function of circulating plasma exosomal miR-146b-5p in microglial polarization and neuroinflammation following ICH.
  • To elucidate the underlying molecular mechanisms involving the TRAF6/NF-κB pathway.

Main Methods:

  • Plasma exosomal miR-146b-5p levels were quantified in ICH patients and healthy controls.
  • In vitro and in vivo models (LPS-induced microglia, ICH mouse models) were used to assess miR-146b-5p's effects.
  • Dual-luciferase reporter assays and TRAF6 manipulation (knockdown/overexpression) were employed to confirm pathway interactions.

Main Results:

  • ICH patients exhibited significantly lower plasma exosomal miR-146b-5p levels compared to controls.
  • miR-146b-5p overexpression promoted M2 microglial polarization and reduced pro-inflammatory cytokines (TNF-α, IL-1β, IL-6).
  • miR-146b-5p directly targeted TRAF6, and its inhibition led to TRAF6 upregulation, NF-κB activation, and M1 polarization.

Conclusions:

  • Circulating exosomal miR-146b-5p plays a crucial role in regulating microglial polarization and neuroinflammation post-ICH.
  • The miR-146b-5p/TRAF6/NF-κB axis represents a potential therapeutic target for mitigating neuroinflammation and promoting neuroprotection in ICH.